-
Biopharma JV Aims to Double Exports with Expansion Plan
A leading biopharmaceutical joint venture (JV), BF Biosciences (BFBIO), has set its sights on doubling its exports through a phased expansion plan. This follows the successful establishment of a state-of-the-art European-standard manufacturing plant, designed in accordance with international regulatory guidelines. Speaking to Dawn, BFBIO Chief Operating Officer Muhammad Farhan shared that the company is poised…
-
Punjab Records 57 New Dengue Cases, Majority in Rawalpindi
The Punjab Health Department has confirmed 57 new cases of dengue within the last 24 hours, with 55 of these cases emerging from Rawalpindi. Bahawalpur and Faisalabad each reported one case. Over the past week, 293 new cases were recorded across the province, raising the total number of dengue infections in Punjab to 843 for…
-
Sindh to Implement Biometric Attendance System Across Hospitals, Announces Health Minister
Sindh Health Minister Dr. Azra Fazal Pechuho has introduced significant reforms aimed at transforming the province’s healthcare system. These initiatives include the introduction of biometric attendance systems in hospitals, improvements in medical training, and strategies to combat the ongoing shortage of anaesthesiologists. During a press briefing, Dr. Azra highlighted that a biometric attendance system will…
-
NIH Issues Advisory for Chikungunya Virus Control Amid Rising Cases in Pakistan
The National Institute of Health (NIH) has released an urgent advisory to help prevent and control the spread of Chikungunya virus across Pakistan, particularly in Karachi and other affected regions. The virus, which is now endemic in several areas, is transmitted by Aedes mosquitoes, the same type responsible for dengue fever transmission. According to the…
-
The Connection Between Napping and Alzheimer’s Disease: What You Need to Know
Recent research suggests a significant link between napping and Alzheimer’s disease, revealing that increased napping could both signal and worsen the symptoms of this condition. A study involving 1,401 older adults found that while napping generally increases with age, those with Alzheimer’s disease experience a more than doubled annual increase in both the frequency and…
-
Antibiotic Resistance Poses Global Threat: 39 Million Deaths Expected Over Next 25 Years
A new study published in The Lancet reveals that antibiotic resistance (AMR) could lead to more than 39 million deaths globally over the next 25 years. This study, conducted by the Global Research on Antimicrobial Resistance (GRAM) Project, provides the first comprehensive global analysis of AMR trends and forecasts future impacts. Between 1990 and 2021,…
-
World Better Positioned Against Mpox Than COVID, Says Gavi Vaccine Alliance
The global approach to tackling the mpox epidemic is significantly improved by the lessons learned from the COVID-19 pandemic, according to the Gavi vaccine alliance. Gavi’s Chief Sania Nishtar emphasized that the COVID-19 pandemic provided critical insights that are now being leveraged in the fight against mpox. “The learnings from COVID have led to the…
-
New XEC Covid Variant: Symptoms and Spread in the UK
A new Covid variant, XEC, is emerging as a potential dominant strain, according to scientists. First identified in Germany in June, XEC cases have since been reported in the UK, US, Denmark, and several other countries, as noted by users on X (formerly Twitter). This variant carries new mutations that could aid its spread this…
-
U.S. Ranks Last in Health Care Among High-Income Nations, Report Reveals
A new report by The Commonwealth Fund has highlighted a concerning reality: the U.S. ranks last among ten high-income countries in critical areas of health care. Despite spending nearly twice as much on health care as its peers—around 18% of its gross domestic product—the U.S. lags behind in preventing deaths, ensuring access to care, and…
-
WHO Prequalifies First Vaccine Against Mpox
The World Health Organization (WHO) has added the MVA-BN vaccine to its prequalification list as the first approved vaccine for mpox. This prequalification aims to ensure timely and expanded access to the vaccine in areas with urgent needs, reducing transmission and containing the outbreak effectively. The approval follows an assessment based on information from the…